NAMS offering history
Every offering-related filing in NewAmsterdam Pharma Co N.V.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 399 filings back to Aug 4, 2022.
| Date | Filing | What it means | |
|---|---|---|---|
| Mar 10, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Mar 10, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Feb 28, 2025 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Dec 13, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Dec 11, 2024 | S-3MEF → | REGISTERED | S-3MEF registration — capacity to sell shares, not a sale yet |
| Dec 10, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 12, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 9, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jul 12, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jul 3, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Apr 19, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Apr 17, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 12, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Mar 8, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Feb 15, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Feb 13, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Dec 19, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 19, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Dec 7, 2023 | F-3 → | REGISTERED | F-3 registration — capacity to sell shares, not a sale yet |
| Nov 13, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Sep 21, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Aug 15, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Aug 11, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 21, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jun 12, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jun 8, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jun 6, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| May 23, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| May 8, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Apr 25, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Apr 24, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jan 31, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jan 30, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jan 17, 2023 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Dec 20, 2022 | F-1 → | REGISTERED | F-1 registration — capacity to sell shares, not a sale yet |
| Oct 18, 2022 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Oct 18, 2022 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
NAMS offering FAQ
When did NAMS last execute an offering?
Per SEC filings, NewAmsterdam Pharma Co N.V.'s most recent priced offering document is a 424B5 filed 2024-12-13. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did NAMS last announce or register an offering?
The most recent registration is a S-3 filed 2025-02-28. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.